Treatment of Substance Use Disorders During the COVID-19 Pandemic with a Focus on MAT

May 11, 2020 11:00 AM -12:00 PM

Behavioral health providers are concerned about the increased risk of overdose related to the pandemic, but there are also issues related to having a substance use disorder (SUD) that increase the risk of developing severe COVID-19. These issues will be explored, along with significant regulatory changes related to COVID-19. We will present regulatory changes and guidance from the Substance Abuse and Mental Health Services Administration (SAMHSA), the Drug Enforcement Administration (DEA) and Office of Civil Rights surrounding prescribing medications for addiction treatment and expanding access to telehealth.